中国心脏起搏与心电生理杂志

参考文献

1 Zipes DP,Camm AJ,Borggrefe M,et al.ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death):developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J].Circulation,2006,114(10):e385

2 Aliot EM,Stevenson WG,Almendral-Garrote JM,et al.EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias:developed in a partnership with the European Heart Rhythm Association (EHRA),a Registered Branch of the European Society of Cardiology (ESC),and the Heart Rhythm Society (HRS);in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)[J].Europace,2009,11(6):771

3 Natale A,Raviele A,Al-Ahmad A,et al.Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation[J].J Cardiovasc Electrophysiol,2010,21(3):339

4 Pedersen CT,Kay GN,Kalman J,et al.EHRA/HRS/APHRS expert consensus on ventricular arrhythmias[J].Europace,2014,16(9):1257

5 Priori SG,Blomstr?m-Lundqvist C,Mazzanti A,et al.2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC).Endorsed by:Association for European Paediatric and Congenital Cardiology (AEPC)[J].Eur Heart J,2015,36(41):2 793

6 Al-Khatib SM,Stevenson WG,Ackerman MJ,et al.2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society[J].J Am Coll Cardiol,2018,72(14):e91

7 Cronin EM,Bogun FM,Maury P,et al.2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias[J].Europace,2019,21(8):1 143

8 Hua W,Zhang LF,Wu YF,et al.Incidence of sudden cardiac death in China:analysis of 4 regional populations[J].J Am Coll Cardiol,2009,54(12):1 110

9 Kennedy HL,Whitlock JA,Sprague MK,et al.Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy[J].N Engl J Med,1985,312(4):193

10 Ng GA.Treating patients with ventricular ectopic beats[J].Heart,2006,92(11):1 707

11 Southall DP,Johnston F,Shinebourne EA,et al.24-hour electrocardiographic study of heart rate and rhythm patterns in population of healthy children[J].Br Heart J,1981,45(3):281

12 Camm AJ,Evans KE,Ward DE,et al.The rhythm of the heart in active elderly subjects[J].Am Heart J,1980,99(5):598

13 向晋涛,吴肇贵,景永明,等.大数据室性并行心律的Lorenz-RR散点图特征及电生理意义[J].中国心脏起搏与心电生理杂志,2016,30(1):5

14 向晋涛.心电散点图的临床应用[J].中国心脏起搏与心电生理杂志,2019,33(3):197

15 Aquaro GD,Pingitore A,Strata E,et al.Cardiac magnetic resonance predicts outcome in patients with premature ventricular complexes of left bundle branch block morphology[J].J Am Coll Cardiol,2010,56(15):1 235

16 Marcus FI,Bluemke DA,Calkins H,et al.Cardiac magnetic resonance for risk stratification of patients with frequent premature ventricular contractions[J].J Am Coll Cardiol,2011,57(15):1 636

17 Bomma C,Rutberg J,Tandri H,et al.Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy[J].J Cardiovasc Electrophysiol,2004,15(3):300

18 Marcus FI,McKenna WJ,Sherrill D,et al.Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia:proposed modification of the Task Force Criteria[J].Eur Heart J,2010,31(7):806

19 Arnar DO,Mairesse GH,Boriani G,et al.Management of asymptomatic arrhythmias:a European Heart Rhythm Association (EHRA) consensus document,endorsed by the Heart Failure Association (HFA),Heart Rhythm Society (HRS),Asia Pacific Heart Rhythm Society (APHRS),Cardiac Arrhythmia Society of Southern Africa (CASSA),and Latin America Heart Rhythm Society (LAHRS)[J].Europace,2019,pii:euz046

20 Yarlagadda RK,Iwai S,Stein KM,et al.Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract[J].Circulation,2005,112(8):1 092

21 Bogun F,Crawford T,Reich S,et al.Radiofrequency ablation of frequent,idiopathic premature ventricular complexes:comparison with a control group without intervention[J].Heart Rhythm,2007,4(7):863

22 Krittayaphong R,Bhuripanyo K,Punlee K,et al.Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease:a randomized placebo-controlled study[J].Am Heart J,2002,144(6):e10

23 Wang J,Li J,Feng B.Shen Song Yang Xin Capsule combined with antiarrhythmic drugs,a new integrative medicine therapy,for the Treatment of Frequent Premature Ventricular Contractions (FPVC):a Meta-analysis of randomized controlled trials[J].Evid Based Complement Alternat Med,2014,2014:976 713

24 Zou JG,Zhang J,Jia ZH,et al.Evaluation of the traditional Chinese medicine Shensongyangxin capsule on treating premature ventricular contractions:a randomized,double-blind,controlled multicenter trial[J].Chin Med J (Engl),2011,124(1):76

25 Hua W,Gao RL,Zhao BC,et al.The efficacy and safety of Wenxin Keli in patients with frequent premature ventricular contractions:a randomized,double-blind,placebo-controlled,parallel-group,multicenter trial[J].Chin Med J (Engl),2015,128(19):2 557

26 Wang X,Hu D,Dang S,et al.Effects of traditional Chinese medicine ShenSong YangXin capsules on heart rhythm and function in congestive heart failure patients with frequent ventricular premature complexes:a randomized,double-blind,multicenter clinical trial[J].Chin Med J (Engl),2017,130(14):1 639

27 Zhang F,Zou J,Yu H,et al.Acute efficacy of a traditional Chinese medicine for treatment of frequent premature ventricular contractions in patients with concomitant sinus bradycardia:results from a double-blind,placebo-controlled,multicentre,randomized clinical trial[J].Evid Based Complement Alternat Med,2019,2019:3 917 282

28 陈刚,樊晓寒,张奎俊,等.特发性右心室流出道室性心律失常起源和射频消融结果影响因素的性别差异[J].中华心律失常学杂志,2018,22(2):134

29 Ding L,Hou B,Wu L,et al.Delayed efficacy of radiofrequency catheter ablation on ventricular arrhythmias originating from the left ventricular anterobasal wall[J].Heart Rhythm,2017,14(3):341

30 Zhang SQ,Zheng C,Li YC,et al.Common and distinctive electrocardiographic characteristics and effective catheter ablation of idiopathic ventricular arrhythmias originating from different areas of ventricular septum adjacent to atrioventricular annulus[J].J Cardiovasc Electrophysiol,2018,29(8):1 104

31 吴灵敏,姚焰,侯炳波,等.经房间隔穿刺途径消融左心室起源的室性心律失常[J].中华心律失常学杂志,2014,18(4):283

32 Winkle RA,Derrington DC,Schroeder JS.Characteristics of ventricular tachycardia in ambulatory patients[J].Am J Cardiol,1977,39(4):487

33 Buxton AE,Duc J,Berger EE,et al.Nonsustained ventricular tachycardia[J].Cardiol Clin,2000,18(2):327

34 Wajngarten M,Grupi C,Bellotti GM,et al.Frequency and significance of cardiac rhythm disturbances in healthy elderly individuals[J].J Electrocardiol,1990,23(2):171

35 Ouyang F,Cappato R,Ernst S,et al.Electroanatomic substrate of idiopathic left ventricular tachycardia:unidirectional block and macroreentry within the purkinje network[J].Circulation,2002,105(4):462

36 Denes P,Gillis AM,Pawitan Y,et al.Prevalence,characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial.CAST Investigators[J].Am J Cardiol,1991,68(9):887

37 Senges JC,Becker R,Schreiner KD,et al.Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria.Multicenter automatic defibrillator implantation trial[J].Pacing Clin Electrophysiol,2002,25(2):183

38 Cheema AN,Sheu K,Parker M,et al.Nonsustained ventricular tachycardia in the setting of acute myocardial infarction:tachycardia characteristics and their prognostic implications[J].Circulation,1998,98(19):2 030

39 Spirito P,Rapezzi C,Autore C,et al.Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia[J].Circulation,1994,90(6):2 743

40 Teerlink JR,Jalaluddin M,Anderson S,et al.Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death.PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators[J].Circulation,2000,101(1):40

41 Kligfield P,Hochreiter C,Niles N,et al.Relation of sudden death in pure mitral regurgitation,with and without mitral valve prolapse,to repetitive ventricular arrhythmias and right and left ventricular ejection fractions[J].Am J Cardiol,1987,60(4):397

42 Pringle SD,Dunn FG,Macfarlane PW,et al.Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy[J].Am J Cardiol,1992,69(9):913

43 Roden DM,Lazzara R,Rosen M,et al.Multiple mechanisms in the long-QT syndrome.Current knowledge,gaps,and future directions.The SADS Foundation Task Force on LQTS[J].Circulation,1996,94(8):1 996

44 Lerman BB,Stein K,Engelstein ED,et al.Mechanism of repetitive monomorphic ventricular tachycardia[J].Circulation,1995,92(3):421

45 Buxton AE,Kleiman RB,Kindwall KE,et al.Endocardial mapping during sinus rhythm in patients with coronary artery disease and nonsustained ventricular tachycardia[J].Am J Cardiol,1993,71(8):695

46 Katritrsis D,Gill JS,Camm AJ.Repetitive monomorphicventricular tachycardia[M]// Zipes DP,Jalife J.Cardiac electrophysiology:from cell to bedside.2nd ed.Philadelphia:WB Saunders,1995:900-906

47 Farmer DM,Swygman CA,Wang PJ,et al.Evidence that nonsustained polymorphic ventricular tachycardia causes syncope (data from implantable cardioverter defibrillators)[J].Am J Cardiol,2003,91(5):606

48 Buxton AE,Marchlinski FE,Doherty JU,et al.Repetitive,monomorphic ventricular tachycardia:clinical and electrophysiologic characteristics in patients with and patients without organic heart disease[J].Am J Cardiol,1984,54(8):997

49 Blanck Z,Jazayeri M,Dhala A,et al.Bundle branch reentry:a mechanism of ventricular tachycardia in the absence of myocardial or valvular dysfunction[J].J Am Coll Cardiol,1993,22(6):1 718

50 Katritrsis D,Camm AJ.Risk stratification of patients with ventricular arrhythmia[M]// Zipes DP,Jalife J.Cardiac electrophysiology:from cell to bedside.3rd ed.Philadelphia:WB Saunders,2000:808-827

51 Jouven X,Zureik M,Desnos M,et al.Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations[J].N Engl J Med,2000,343(12):826

52 Priori SG,Schwartz PJ,Napolitano C,et al.Risk stratification in the long-QT syndrome[J].N Engl J Med,2003,348(19):1 866

53 Spirito P,Bellone P,Harris KM,et al.Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy[J].N Engl J Med,2000,342(24):1 778

54 Barsheshet A,Goldenberg I,O-Uchi J,et al.Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events:implications for mutation-specific response to β-blocker therapy in type 1 long-QT syndrome[J].Circulation,2012,125(16):1 988

55 Moss AJ,Zareba W,Kaufman ES,et al.Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel[J].Circulation,2002,105(7):794

56 Yamashina Y,Yagi T,Namekawa A,et al.Distribution of successful ablation sites of idiopathic right ventricular outflow tract tachycardia[J].Pacing Clin Electrophysiol,2009,32(6):727

57 Shimizu W.Arrhythmias originating from the right ventricular outflow tract:how to distinguish "malignant" from "benign" [J].Heart Rhythm,2009,6(10):1 507

58 Stevenson WG,Soejima K.Catheter ablation for ventricular tachycardia[J].Circulation,2007,115(21):2 750

59 Betensky BP,Park RE,Marchlinski FE,et al.The V(2) transition ratio:a new electrocardiographic criterion for distinguishing left from right ventricular outflow tract tachycardia origin[J].J Am Coll Cardiol,2011,57(22):2 255

60 Bala R,Garcia FC,Hutchinson MD,et al.Electrocardiographic and electrophysiologic features of ventricular arrhythmias originating from the right/left coronary cusp commissure[J].Heart Rhythm,2010,7(3):312

61 Tanner H,Hindricks G,Schirdewahn P,et al.Outflow tract tachycardia with R/S transition in lead V3:six different anatomic approaches for successful ablation[J].J Am Coll Cardiol,2005,45(3):418

62 Priori SG,Wilde AA,Horie M,et al.Executive summary:HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes[J].Europace,2013,15(10):1 389

63 Basso C,Corrado D,Thiene G.Cardiovascular causes of sudden death in young individuals including athletes[J].Cardiol Rev,1999,7(3):127

64 Tabib A,Loire R,Chalabreysse L,et al.Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia[J].Circulation,2003,108(24):3 000

65 Groh WJ.Arrhythmias in the muscular dystrophies[J].Heart Rhythm,2012,9(11):1 890

66 Bardy GH,Lee KL,Mark DB,et al.Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure[J].N Engl J Med,2005,352(3):225

67 Buxton AE,Calkins H,Callans DJ,et al.ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology)[J].J Am Coll Cardiol,2006,48(11):2 360

68 Lampert R,Wang Y,Curtis JP.Variation among hospitals in selection of higher-cost,"higher-tech," implantable cardioverter-defibrillators:data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry[J].Am Heart J,2013,165(6):1 015

69 Klein LS,Shih HT,Hackett FK,et al.Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease[J].Circulation,1992,85(5):1 666

70 Iwai S,Cantillon DJ,Kim RJ,et al.Right and left ventricular outflow tract tachycardias:evidence for a common electrophysiologic mechanism[J].J Cardiovasc Electrophysiol,2006,17(10):1 052

71 Iwai S,Lerman BB.Management of ventricular tachycardia in patients with clinically normal hearts[J].Curr Cardiol Rep,2000,2(6):515

72 Soejima K,Suzuki M,Maisel WH,et al.Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction:short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping[J].Circulation,2001,104(6):664

73 Fananapazir L,Tracy CM,Leon MB,et al.Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy.A consecutive analysis in 155 patients[J].Circulation,1989,80(5):1 259

74 Soejima K,Stevenson WG,Sapp JL,et al.Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy:the importance of low-voltage scars[J].J Am Coll Cardiol,2004,43(10):1 834

75 Blanck Z,Dhala A,Deshpande S,et al.Bundle branch reentrant ventricular tachycardia:cumulative experience in 48 patients[J].J Cardiovasc Electrophysiol,1993,4(3):253

76 Lopera G,Stevenson WG,Soejima K,et al.Identification and ablation of three types of ventricular tachycardia involving the his-purkinje system in patients with heart disease[J].J Cardiovasc Electrophysiol,2004,15(1):52

77 Das MK,Khan B,Jacob S,et al.Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease[J].Circulation,2006,113(21):2 495

78 Zimmerman SL,Nazarian S.Cardiac MRI in the treatment of arrhythmias[J].Expert Rev Cardiovasc Ther,2013,11(7):843

79 Gomes JA,Cain ME,Buxton AE,et al.Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia,coronary artery disease,and left ventricular dysfunction[J].Circulation,2001,104(4):436

80 Kamath GS,Zareba W,Delaney J,et al.Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia[J].Heart Rhythm,2011,8(2):256

81 Buxton AE,Lee KL,DiCarlo L,et al.Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death.Multicenter Unsustained Tachycardia Trial Investigators[J].N Engl J Med,2000,342(26):1 937

82 Scanlon PJ,Faxon DP,Audet AM,et al.ACC/AHA Guidelines for coronary angiography.A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography).Developed in collaboration with the Society for Cardiac Angiography and Interventions[J].J Am Coll Cardiol,1999,33(6):1 756

83 Dickfeld T,Kocher C.The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations[J].Curr Cardiol Rep,2008,10(2):149

84 Bloch Thomsen PE,Jons C,Raatikainen MJ,et al.Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction:the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study[J].Circulation,2010,122(13):1 258

85 Epstein AE,DiMarco JP,Ellenbogen KA,et al.ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices):developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.[J].Circulation,2008,117(21) :e350

86 Poole JE,Johnson GW,Hellkamp AS,et al.Prognostic importance of defibrillator shocks in patients with heart failure[J].N Engl J Med,2008,359(10):1 009

87 Moss AJ,Schuger C,Beck CA,et al.Reduction in inappropriate therapy and mortality through ICD programming[J].N Engl J Med,2012,367(24):2 275

88 Carbucicchio C,Santamaria M,Trevisi N,et al.Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators:short- and long-term outcomes in a prospective single-center study[J].Circulation,2008,117(4):462

89 Gill JS,Mehta D,Ward DE,et al.Efficacy of flecainide,sotalol,and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality[J].Br Heart J,1992,68(4):392

90 Park KM,Kim YH,Marchlinski FE.Using the surface electrocardiogram to localize the origin of idiopathic ventricular tachycardia[J].Pacing Clin Electrophysiol,2012,35(12):1 516

91 Steinberg JS,Martins J,Sadanandan S,et al.Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study[J].Am Heart J,2001,142(3):520

92 Connolly SJ,Dorian P,Roberts RS,et al.Comparison of beta-blockers,amiodarone plus beta-blockers,or sotalol for prevention of shocks from implantable cardioverter defibrillators:the OPTIC Study:a randomized trial[J].JAMA,2006,295(2):165

93 Seidl K,Hauer B,Schwick NG,et al.Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator[J].Am J Cardiol,1998,82(6):744

94 Connolly SJ,Hallstrom AP,Cappato R,et al.Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials.AVID,CASH and CIDS studies.Antiarrhythmics vs Implantable Defibrillator study.Cardiac Arrest Study Hamburg .Canadian Implantable Defibrillator Study[J].Eur Heart J,2000,21(24):2 071

95 Mallidi J,Nadkarni GN,Berger RD,et al.Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease[J].Heart Rhythm,2011,8(4):503

96 Al-Khatib SM,Daubert JP,Anstrom KJ,et al.Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial[J].J Cardiovasc Electrophysiol,2015,26(2):151

97 Wissner E,Stevenson WG,Kuck KH.Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy:where are we today?A clinical review[J].Eur Heart J,2012,33(12):1 440

98 El-Damaty A,Sapp JL.The role of catheter ablation for ventricular tachycardia in patients with ischemic heart disease[J].Curr Opin Cardiol,2011,26(1):30

99 Sartipy U,Alb?ge A,Insulander P,et al.Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration:the Karolinska approach[J].J Interv Card Electrophysiol,2007,19(3):171

100 刘霞,戚文航.心室扑动和心室颤动[M]//陈新.临床心律失常学.第2版.北京:人民卫生出版社,2009:540-551

101 Ae E.Ventricular fibrillation [M]// Zipes DP,Jalife J.Cardiac electrophysiology:from cell to bedside.4th ed.Philadelphia:WB Saunders,2004:

102 鲁志兵,江洪.心室颤动的发生机制和射频消融治疗[J].中华心律失常学杂志,2009,13(2):126

103 Napolitano C,Bloise R,Monteforte N,et al.Sudden cardiac death and genetic ion channelopathies:long QT,Brugada,short QT,catecholaminergic polymorphic ventricular tachycardia,and idiopathic ventricular fibrillation[J].Circulation,2012,125(16):2 027

104 Prystowsky EN,Padanilam BJ,Joshi S,et al.Ventricular arrhythmias in the absence of structural heart disease[J].J Am Coll Cardiol,2012,59(20):1 733

105 Kaufman ES.Mechanisms and clinical management of inherited channelopathies:long QT syndrome,Brugada syndrome,catecholaminergic polymorphic ventricular tachycardia,and short QT syndrome[J].Heart Rhythm,2009,6(8 Suppl):S51

106 Schwartz PJ,Priori SG,Locati EH,et al.Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate.Implications for gene-specific therapy[J].Circulation,1995,92(12):3 381

107 Swan H,Viitasalo M,Piippo K,et al.Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects[J].J Am Coll Cardiol,1999,34(3):823

108 Sy RW,van der Werf C,Chattha IS,et al.Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands[J].Circulation,2011,124(20):2 187

109 Antzelevitch C,Brugada P,Borggrefe M,et al.Brugada syndrome:report of the second consensus conference[J].Heart Rhythm,2005,2(4):429

110 Shimizu W,Noda T,Takaki H,et al.Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome[J].J Am Coll Cardiol,2003,41(4):633

111 Shimizu W,Noda T,Takaki H,et al.Diagnostic value of epinephrine test for genotyping LQT1,LQT2,and LQT3 forms of congenital long QT syndrome[J].Heart Rhythm,2004,1(3):276

112 Vyas H,Ackerman MJ.Epinephrine QT stress testing in congenital long QT syndrome[J].J Electrocardiol,2006,39(4 Suppl):S107

113 Haissaguerre M,Le Métayer P,D'Ivernois C,et al.Distinctive response of arrhythmogenic right ventricular disease to high dose isoproterenol[J].Pacing Clin Electrophysiol,1990,13(12 Pt 2):2 119

114 Brenyo A,Pietrasik G,Barsheshet A,et al.QRS fragmentation and the risk of sudden cardiac death in MADIT II[J].J Cardiovasc Electrophysiol,2012,23(12):1 343

115 Teodorescu C,Reinier K,Uy-Evanado A,et al.Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease,independent of prolonged ventricular repolarization[J].Heart Rhythm,2011,8(10):1 562

116 吴肇贵,向晋涛,黄从新.穿戴式心脏转复除颤器预防心脏性猝死临床应用概况[J].中国心脏起搏与心电生理杂志,2017,31(1):55

117 Belhassen B,Glick A,Viskin S.Efficacy of quinidine in high-risk patients with Brugada syndrome[J].Circulation,2004,110(13):1 731

118 周前,李毅刚.Brugada综合征的药物治疗[J].中国心脏起搏与心电生理杂志,2016,30(4):363

119 Giustetto C,Schimpf R,Mazzanti A,et al.Long-term follow-up of patients with short QT syndrome[J].J Am Coll Cardiol,2011,58(6):587

120 Ha?ssaguerre M,Sacher F,Nogami A,et al.Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy[J].J Am Coll Cardiol,2009,53(7):612

121 Rosso R,Kalman JM,Rogowski O,et al.Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia[J].Heart Rhythm,2007,4(9):1 149

122 Swan H,Laitinen P,Kontula K,et al.Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations[J].J Cardiovasc Electrophysiol,2005,16(2):162

123 van der Werf C,Kannankeril PJ,Sacher F,et al.Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia[J].J Am Coll Cardiol,2011,57(22):2 244

124 Moss AJ,Windle JR,Hall WJ,et al.Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation):a randomized,double-blind,placebo-controlled clinical trial[J].Ann Noninvasive Electrocardiol,2005,10(4 Suppl):59

125 Bode K,Hindricks G,Piorkowski C,et al.Ablation of polymorphic ventricular tachycardias in patients with structural heart disease[J].Pacing Clin Electrophysiol,2008,31(12):1 585

126 Nogami A.Purkinje-related arrhythmias part ii:polymorphic ventricular tachycardia and ventricular fibrillation[J].Pacing Clin Electrophysiol,2011,34(8):1 034

127 Ha?ssaguerre M,Extramiana F,Hocini M,et al.Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes[J].Circulation,2003,108(8):925

128 Ha?ssaguerre M,Shoda M,Ja?s P,et al.Mapping and ablation of idiopathic ventricular fibrillation[J].Circulation,2002,106(8):962

129 Kaneshiro T,Naruse Y,Nogami A,et al.Successful catheter ablation of bidirectional ventricular premature contractions triggering ventricular fibrillation in catecholaminergic polymorphic ventricular tachycardia with RyR2 mutation[J].Circ Arrhythm Electrophysiol,2012,5(1):e14

130 Ha?ssaguerre M,Shah DC,Ja?s P,et al.Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation[J].Lancet,2002,359(9307):677

131 Uemura T,Yamabe H,Tanaka Y,et al.Catheter ablation of a polymorphic ventricular tachycardia inducing monofocal premature ventricular complex[J].Intern Med,2008,47(20):1 799

132 Sacher F,Jesel L,Ja?s P,et al.Insight into the mechanism of Brugada syndrome:epicardial substrate and modification during ajmaline testing[J].Heart Rhythm,2014,11(4):732

133 Nademanee K,Veerakul G,Chandanamattha P,et al.Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium[J].Circulation,2011,123(12):1 270

134 Sacher F,Wright M,Derval N,et al.Endocardial versus epicardial ventricular radiofrequency ablation:utility of in vivo contact force assessment[J].Circ Arrhythm Electrophysiol,2013,6(1):144

135 De Ferrari GM,Dusi V,Spazzolini C,et al.Clinical management of catecholaminergic polymorphic ventricular tachycardia:the role of left cardiac sympathetic denervation[J].Circulation,2015,131(25):2 185

136 Wilde AA,Bhuiyan ZA,Crotti L,et al.Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia[J].N Engl J Med,2008,358(19):2 024

137 Yu L,Huang B,Zhou X,et al.Renal sympathetic stimulation and ablation affect ventricular arrhythmia by modulating autonomic activity in a cesium-induced long QT canine model[J].Heart Rhythm,2017,14(6):912

138 Liu S,Yu X,Luo D,et al.Ablation of the ligament of Marshall and left stellate ganglion similarly reduces ventricular arrhythmias during acute myocardial infarction[J].Circ Arrhythm Electrophysiol,2018,11(5):e005945

139 Wang S,Zhou X,Huang B,et al.Spinal cord stimulation protects against ventricular arrhythmias by suppressing left stellate ganglion neural activity in an acute myocardial infarction canine model[J].Heart Rhythm,2015,12(7):1 628

140 Wang J,Dai M,Cao Q,et al.Carotid baroreceptor stimulation suppresses ventricular fibrillation in canines with chronic heart failure[J].Basic Res Cardiol,2019,114(6):41

141 Yu L,Wang S,Zhou X,et al.Chronic intermittent low-level stimulation of tragus reduces cardiac autonomic remodeling and ventricular arrhythmia inducibility in a post-infarction canine model[J].JACC Clin Electrophysiol,2016,2(3):330

142 Armaganijan LV,Staico R,Moreira DA,et al.6-Month outcomes in patients with implantable cardioverter-defibrillators undergoing renal sympathetic denervation for the treatment of refractory ventricular arrhythmias[J].JACC Cardiovasc Interv,2015,8(7):984

143 Evranos B,Canpolat U,Kocyigit D,et al.Role of adjuvant renal sympathetic denervation in the treatment of ventricular arrhythmias[J].Am J Cardiol,2016,118(8):1 207

144 Yu L,Huang B,Po SS,et al.Low-level tragus stimulation for the treatment of ischemia and reperfusion injury in patients with ST-segment elevation myocardial infarction:a proof-of-concept study[J].JACC Cardiovasc Interv,2017,10(15):1 511

145 Benjamin EJ,Blaha MJ,Chiuve SE,et al.Heart disease and stroke statistics-2017 update:a report from the American Heart Association[J].Circulation,2017,135(10):e146

146 Wong CX,Brown A,Lau DH,et al.Epidemiology of sudden cardiac death:global and regional perspectives[J].Heart Lung Circ,2019,28(1):6

147 Myerburg RJ,Junttila MJ.Sudden cardiac death caused by coronary heart disease[J].Circulation,2012,125(8):1 043

148 Yancy CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2013,62(16):e147

149 Zhang S,Ching CK,Huang D,et al.Utilization of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in emerging countries:Improve SCA clinical trial[J].Heart Rhythm,2020,17(3):468

150 Towbin JA,McKenna WJ,Abrams DJ,et al.2019 HRS expert consensus statement on evaluation,risk stratification,and management of arrhythmogenic cardiomyopathy[J].Heart Rhythm,2019,16(11):e301

151 王龙.心室颤动[M] //Zipes DP,Jalife J.郭继鸿,李学斌,译.心脏电生理:从细胞到临床.第4版.北京:北京大学医学出版社,2008:697-702

152 Barsky AJ,Ahern DK,Bailey ED,et al.Predictors of persistent palpitations and continued medical utilization[J].J Fam Pract,1996,42(5):465

153 Ibanez B,James S,Agewall S,et al.2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)[J].Eur Heart J,2018,39(2):119

154 Panchal AR,Berg KM,Hirsch KG,et al.2019 American Heart Association focused update on advanced cardiovascular life support:use of advanced airways,vasopressors,and extracorporeal cardiopulmonary resuscitation during cardiac arrest:an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care[J].Circulation,2019,140(24):e881

155 中华医学会心血管病学分会,中国生物医学工程学会心律分会,胺碘酮抗心律失常治疗应用指南工作组.胺碘酮抗心律失常治疗应用指南(2008)[J].中国心脏起搏与心电生理杂志,2008,22(5):377

156 胺碘酮规范应用专家建议专家写作组.胺碘酮规范应用专家建议[J].中华内科杂志,2019,58(4):258

157 中国生物医学工程学会心律分会心律失常药物工作委员会.索他洛尔抗心律失常中国专家共识[J].中国循环杂志,2019,34(8):741

158 Ponikowski P,Voors AA,Anker SD,et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J].Eur Heart J,2016,37(27):2 129

159 华伟,牛红霞,李学斌,等.全皮下植入型心律转复除颤器的国内初步临床应用[J].中华心律失常学杂志,2017,21(2):112

160 华伟,杨杰孚,王玉堂,等.可穿戴式除颤器中国多中心临床观察性研究[J].中华心律失常学杂志,2020,24(1):41

161 中华医学会心血管病学分会,中国生物医学工程学会心律分会,中国医师协会循证医学专业委员会,等.心律失常紧急处理专家共识[J].中华心血管病杂志,2013,41(5):363

162 Latif S,Dixit S,Callans DJ.Ventricular arrhythmias in normal hearts[J].Cardiol Clin,2008,26(3):367

163 王国干.常见室性心律失常的急诊处理[J].中国心血管杂志,2009,14(6):498

164 Keren A,Tzivoni D,Gavish D,et al.Etiology,warning signs and therapy of torsade de pointes.A study of 10 patients[J].Circulation,1981,64(6):1 167

165 Abu-Zeitone A,Peterson DR,Polonsky B,et al.Efficacy of different beta-blockers in the treatment of long QT syndrome[J].J Am Coll Cardiol,2014,64(13):1 352

166 Villafaňe J,Atallah J,Gollob MH,et al.Long-term follow-up of a pediatric cohort with short QT syndrome[J].J Am Coll Cardiol,2013,61(11):1 183

167 Roston TM,Vinocur JM,Maginot KR,et al.Catecholaminergic polymorphic ventricular tachycardia in children:analysis of therapeutic strategies and outcomes from an international multicenter registry[J].Circ Arrhythm Electrophysiol,2015,8(3):633

168 Kannankeril PJ,Moore JP,Cerrone M,et al.Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia:a randomized clinical trial[J].JAMA Cardiol,2017,2(7):759

169 Panchal AR,Berg KM,Kudenchuk PJ,et al.2018 American Heart Association focused update on advanced cardiovascular life support use of antiarrhythmic drugs during and immediately after cardiac arrest:an update to the American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care[J].Circulation,2018,138(23):e740

170 Kudenchuk PJ,Brown SP,Daya M,et al.Amiodarone,lidocaine,or placebo in out-of-hospital cardiac arrest[J].N Engl J Med,2016,374(18):1 711

171 Kleinman ME,Goldberger ZD,Rea T,et al.2017 American Heart Association Focused update on adult basic life support and cardiopulmonary resuscitation quality:an update to the American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care[J].Circulation,2018,137(1):e7

172 Dan GA,Martinez-Rubio A,Agewall S,et al.Antiarrhythmic drugs-clinical use and clinical decision making:a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology,endorsed by the Heart Rhythm Society (HRS),Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)[J].Europace,2018,20(5):731

173 Dumas F,Cariou A,Manzo-Silberman S,et al.Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest:insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry[J].Circ Cardiovasc Interv,2010,3(3):200

174 Gupta S,Pressman GS,Figueredo VM.Incidence of,predictors for,and mortality associated with malignant ventricular arrhythmias in non-ST elevation myocardial infarction patients[J].Coron Artery Dis,2010,21(8):460

175 Brugada J,Aguinaga L,Mont L,et al.Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction:effects on the electrophysiologic substrate and outcome[J].J Am Coll Cardiol,2001,37(2):529

176 Kontogiannis C,Tampakis K,Georgiopoulos G,et al.Electrical storm:current evidence,clinical implications,and future perspectives[J].Curr Cardiol Rep,2019,21(9):96

177 Claro JC,Candia R,Rada G,et al.Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death[J].Cochrane Database Syst Rev,2015,(12):CD008093

178 Bunch TJ,Mahapatra S,Murdock D,et al.Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks[J].Pacing Clin Electrophysiol,2011,34(12):1 600

179 Cardiac Arrhythmia Suppression Trial II Investigators.Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction[J].N Engl J Med,1992,327(4):227

180 Kuck KH,Cappato R,Siebels J,et al.Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest :the Cardiac Arrest Study Hamburg (CASH)[J].Circulation,2000,102(7):748

181 Frankel DS,Mountantonakis SE,Robinson MR,et al.Ventricular tachycardia ablation remains treatment of last resort in structural heart disease:argument for earlier intervention[J].J Cardiovasc Electrophysiol,2011,22(10):1 123

182 Peichl P,Cihák R,Kozeluhová M,et al.Catheter ablation of arrhythmic storm triggered by monomorphic ectopic beats in patients with coronary artery disease[J].J Interv Card Electrophysiol,2010,27(1):51

183 Guo JR,Zheng LH,Wu LM,et al.Aneurysm-related ischemic ventricular tachycardia:safety and efficacy of catheter ablation[J].Medicine (Baltimore),2017,96(13):e6 442

184 沈才杰,储慧民,陈晓敏.心外膜室性心动过速的研究进展[J].中国心脏起搏与心电生理杂志,2011,25(6):543

185 薛玉梅,詹贤章,廖洪涛,等.经皮心包穿刺术进行室性心律失常心外膜标测和消融的应用体会[J].中华心律失常学杂志,2015,19(1):15

186 Yoshiga Y,Mathew S,Wissner E,et al.Correlation between substrate location and ablation strategy in patients with ventricular tachycardia late after myocardial infarction[J].Heart Rhythm,2012,9(8):1 192

187 Sartipy U,Alb?ge A,Str??t E,et al.Surgery for ventricular tachycardia in patients undergoing left ventricular reconstruction by the Dor procedure[J].Ann Thorac Surg,2006,81(1):65

188 Patel M,Rojas F,Shabari FR,et al.Safety and feasibility of open chest epicardial mapping and ablation of ventricular tachycardia during the period of left ventricular assist device implantation[J].J Cardiovasc Electrophysiol,2016,27(1):95

189 Mulloy DP,Bhamidipati CM,Stone ML,et al.Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias[J].J Thorac Cardiovasc Surg,2013,145(5):1 207

190 黄德嘉,霍勇,张澍,等.冠心病血运重建后心脏性猝死的预防[J].中华心律失常学杂志,2017,21(1):9

191 Hohnloser SH,Kuck KH,Dorian P,et al.Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction[J].N Engl J Med,2004,351(24):2 481

192 Steinbeck G,Andresen D,Seidl K,et al.Defibrillator implantation early after myocardial infarction[J].N Engl J Med,2009,361(15):1 427

193 Moss AJ,Hall WJ,Cannom DS,et al.Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.Multicenter Automatic Defibrillator Implantation Trial Investigators[J].N Engl J Med,1996,335(26):1933

194 中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会.室性心律失常中国专家共识[J].中国心脏起搏与心电生理杂志,2016,30(4):283

195 晏煜昊,单其俊.心肌纤维化:室性心律失常的重要预测因子[J].中国心脏起搏与心电生理杂志,2018,32(02):166

196 Greulich S,Deluigi CC,Gloekler S,et al.CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis[J].JACC Cardiovasc Imaging,2013,6(4):501

197 Sveinbjornsson G,Olafsdottir EF,Thorolfsdottir RB,et al.Variants in NKX2-5 and FLNC cause dilated cardiomyopathy and sudden cardiac death[J].Circ Genom Precis Med,2018,11(8):e002151

198 Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators.A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias[J].N Engl J Med,1997,337(22):1 576

199 Connolly SJ,Gent M,Roberts RS,et al.Canadian implantable defibrillator study (CIDS) :a randomized trial of the implantable cardioverter defibrillator against amiodarone[J].Circulation,2000,101(11):1 297

200 杜为,刘榜霞,李小荣,等.单中心室性心动过速患者的临床特征与治疗现状分析[J].中国心脏起搏与心电生理杂志,2016,30(5):395

201 Kadish A,Dyer A,Daubert JP,et al.Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy[J].N Engl J Med,2004,350(21):2 151

202 Al-Khatib SM,Fonarow GC,Joglar JA,et al.Primary prevention implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy:a Meta-analysis[J].JAMA Cardiol,2017,2(6):685

203 Li YG,Gr?nefeld G,Israel C,et al.Sustained monomorphic ventricular tachycardia ablation from the aortic sinus of valsalva[J].J Cardiovasc Electrophysiol,2002,13(2):130

204 Delacretaz E,Stevenson WG,Ellison KE,et al.Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease[J].J Cardiovasc Electrophysiol,2000,11(1):11

205 Cantillon DJ,Bianco C,Wazni OM,et al.Electrophysiologic characteristics and catheter ablation of ventricular tachyarrhythmias among patients with heart failure on ventricular assist device support[J].Heart Rhythm,2012,9(6):859

206 Romero J,Santangeli P,Pathak RK,et al.Bundle branch reentrant ventricular tachycardia:review and case presentation[J].J Interv Card Electrophysiol,2018,52(3):385

207 Li W,Yu Y,Hou JW,et al.Larger rate dependence of late sodium current in cardiac Purkinje cells:a potential link to arrhythmogenesis[J].Heart Rhythm,2017,14(3):422

208 Hou JW,Li W,Guo K,et al.Antiarrhythmic effects and potential mechanism of WenXin KeLi in cardiac Purkinje cells[J].Heart Rhythm,2016,13(4):973

209 Li YG,Gr?nefeld G,Israel C,et al.Bundle branch reentrant tachycardia in patients with apparent normal His-Purkinje conduction:the role of functional conduction impairment[J].J Cardiovasc Electrophysiol,2002,13(12):1 233

210 te Riele AS,James CA,Groeneweg JA,et al.Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy[J].Eur Heart J,2016,37(9):755

211 Bao JR,Wang JZ,Yao Y,et al.Screening of pathogenic genes in Chinese patients with arrhythmogenic right ventricular cardiomyopathy[J].Chin Med J (Engl),2013,126(22):4 238

212 Bao J,Wang J,Yao Y,et al.Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy[J].Circ Cardiovasc Genet,2013,6(6):552

213 Te Riele AS,James CA,Philips B,et al.Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy:the triangle of dysplasia displaced[J].J Cardiovasc Electrophysiol,2013,24(12):1 311

214 Rastegar N,Zimmerman SL,Te Riele A,et al.Spectrum of Biventricular Involvement on CMR Among Carriers of ARVD/C-Associated Mutations[J].JACC Cardiovasc Imaging,2015,8(7):863

215 萧湛潮,雷娟,周淑娴,等.国内致心律失常性右室心肌病文献病例分析[J].中国心脏起搏与心电生理杂志,2014,28(2):132

216 Link MS,Laidlaw D,Polonsky B,et al.Ventricular arrhythmias in the North American multidisciplinary study of ARVC:predictors,characteristics,and treatment[J].J Am Coll Cardiol,2014,64(2):119

217 Marcus GM,Glidden DV,Polonsky B,et al.Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy:a report from the North American ARVC Registry[J].J Am Coll Cardiol,2009,54(7):609

218 Saberniak J,Hasselberg NE,Borgquist R,et al.Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members[J].Eur J Heart Fail,2014,16(12):1 337

219 Kapplinger JD,Landstrom AP,Salisbury BA,et al.Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise[J].J Am Coll Cardiol,2011,57(23):2 317

220 Wang Y,Li C,Shi L,et al.Integrin β1D deficiency-mediated RyR2 dysfunction contributes to catecholamine-sensitive ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy[J].Circulation,2020,141(18):1 477

221 Bhonsale A,James CA,Tichnell C,et al.Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention[J].J Am Coll Cardiol,2011,58(14):1 485

222 Maron BJ,Spirito P,Shen WK,et al.Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy[J].JAMA,2007,298(4):405

223 Rowin EJ,Maron BJ,Haas TS,et al.Hypertrophic cardiomyopathy with left ventricular apical aneurysm:implications for risk stratification and management[J].J Am Coll Cardiol,2017,69(7):761

224 Maron BJ,Shen WK,Link MS,et al.Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy[J].N Engl J Med,2000,342(6):365

225 Adabag AS,Kuskowski MA,Maron BJ.Determinants for clinical diagnosis of hypertrophic cardiomyopathy[J].Am J Cardiol,2006,98(11):1 507

226 Melacini P,Maron BJ,Bobbo F,et al.Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy[J].Heart,2007,93(6):708

227 Inada K,Seiler J,Roberts-Thomson KC,et al.Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy[J].J Cardiovasc Electrophysiol,2011,22(1):41

228 Saltzman HE.Arrhythmias and heart failure[J].Cardiol Clin,2014,32(1) :125

229 Dimitropoulos G,Leventogiannis G,De Bono J.Decompensated heart failure with ventricular arrhythmia:how useful is VT ablation[J]?Curr Heart Fail Rep,2018,15(4):201

230 Hjalmarson A,Goldstein S,Fagerberg B,et al.Effects of controlled-release metoprolol on total mortality,hospitalizations,and well-being in patients with heart failure:the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF).MERIT-HF Study Group[J].JAMA,2000,283(10):1 295

231 Dargie HJ.Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction:the CAPRICORN randomised trial[J].Lancet,2001,357(9266):1 385

232 Cohn JN,Johnson G,Ziesche S,et al.A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure[J].N Engl J Med,1991,325(5):303

233 McMurray JJ,Ostergren J,Swedberg K,et al.Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:the CHARM-Added trial[J].Lancet,2003,362(9386):767

234 Pitt B,Remme W,Zannad F,et al.Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction[J].N Engl J Med,2003,348(14):1 309

235 Desai AS,McMurray JJ,Packer M,et al.Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients[J].Eur Heart J,2015,36(30):1 990

236 Martens P,Nuyens D,Rivero-Ayerza M,et al.Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction[J].Clin Res Cardiol,2019,108(10):1 074

237 Cho JH,Zhang R,Kilfoil PJ,et al.Delayed repolarization underlies ventricular arrhythmias in rats with heart failure and preserved ejection fraction[J].Circulation,2017,136(21):2 037

238 Cho JH,Zhang R,Aynaszyan S,et al.Ventricular arrhythmias underlie sudden death in rats with heart failure and preserved ejection fraction[J].Circ Arrhythm Electrophysiol,2018,11(8):e006452

239 Vaduganathan M,Patel RB,Michel A,et al.Mode of death in heart failure with preserved ejection fraction[J].J Am Coll Cardiol,2017,69(5):556

240 Martin N,Manoharan K,Thomas J,et al.Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction[J].Cochrane Database Syst Rev,2018,6:CD012721

241 Zhang D,Tu H,Wadman MC,et al.Substrates and potential therapeutics of ventricular arrhythmias in heart failure[J].Eur J Pharmacol,2018,833:349

242 Kolodziejczak M,Andreotti F,Kowalewski M,et al.Implantable cardioverter-defibrillators for primary prevention in patients with ischemic or nonischemic cardiomyopathy:a systematic review and Meta-analysis[J].Ann Intern Med,2017,167(2):103

243 Beggs S,Jhund PS,Jackson CE,et al.Non-ischaemic cardiomyopathy,sudden death and implantable defibrillators:a review and meta-analysis[J].Heart,2018,104(2):144

244 Barra S,Providência R,Duehmke R,et al.Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator:a systematic review and proportional meta-analysis[J].Europace,2018,20(3):481

245 Silka MJ,Hardy BG,Menashe VD,et al.A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects[J].J Am Coll Cardiol,1998,32(1):245

246 Koyak Z,Harris L,de Groot JR,et al.Sudden cardiac death in adult congenital heart disease[J].Circulation,2012,126(16):1 944

247 Khairy P,Van Hare GF,Balaji S,et al.PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease:developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS).Endorsed by the governing bodies of PACES,HRS,the American College of Cardiology (ACC),the American Heart Association (AHA),the European Heart Rhythm Association (EHRA),the Canadian Heart Rhythm Society (CHRS),and the International Society for Adult Congenital Heart Disease (ISACHD)[J].Can J Cardiol,2014,30(10):e1

248 Khairy P,Aboulhosn J,Gurvitz MZ,et al.Arrhythmia burden in adults with surgically repaired tetralogy of Fallot:a multi-institutional study[J].Circulation,2010,122(9):868

249 Gatzoulis MA,Balaji S,Webber SA,et al.Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot:a multicentre study[J].Lancet,2000,356(9234):975

250 Kammeraad JA,van Deurzen CH,Sreeram N,et al.Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries[J].J Am Coll Cardiol,2004,44(5):1 095

251 Harrison DA,Harris L,Siu SC,et al.Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot[J].J Am Coll Cardiol,1997,30(5):1 368

252 Knauth AL,Gauvreau K,Powell AJ,et al.Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair[J].Heart,2008,94(2):211

253 Diller GP,Kempny A,Liodakis E,et al.Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot[J].Circulation,2012,125(20):2 440

254 Therrien J,Siu SC,Harris L,et al.Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot[J].Circulation,2001,103(20):2 489

255 Miyazaki A,Sakaguchi H,Ohuchi H,et al.Efficacy of hemodynamic-based management of tachyarrhythmia after repair of tetralogy of Fallot[J].Circ J,2012,76(12):2 855

256 Mavroudis C,Deal BJ,Backer CL,et al.Arrhythmia surgery in patients with and without congenital heart disease[J].Ann Thorac Surg,2008,86(3):857

257 Epstein AE,DiMarco JP,Ellenbogen KA,et al.2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J].Circulation,2013,127(3):e283

258 Zeppenfeld K,Schalij MJ,Bartelings MM,et al.Catheter ablation of ventricular tachycardia after repair of congenital heart disease:electroanatomic identification of the critical right ventricular isthmus[J].Circulation,2007,116(20):2 241

259 王祖禄,黄从新,梁延春,等.应用电解剖标测系统引导经盐水灌注导管消融法洛四联症术后的室性心动过速[J].中华心律失常学杂志,2007,11(2):95

260 Morwood JG,Triedman JK,Berul CI,et al.Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease[J].Heart Rhythm,2004,1(3):301

261 Tokuda M,Tedrow UB,Kojodjojo P,et al.Catheter ablation of ventricular tachycardia in nonischemic heart disease[J].Circ Arrhythm Electrophysiol,2012,5(5):992

262 Kapel GF,Reichlin T,Wijnmaalen AP,et al.Left-sided ablation of ventricular tachycardia in adults with repaired tetralogy of Fallot:a case series[J].Circ Arrhythm Electrophysiol,2014,7(5):889

263 Kapel GF,Reichlin T,Wijnmaalen AP,et al.Re-entry using anatomically determined isthmuses:a curable ventricular tachycardia in repaired congenital heart disease[J].Circ Arrhythm Electrophysiol,2015,8(1):102

264 Kapel GF,Sacher F,Dekkers OM,et al.Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired Tetralogy of Fallot[J].Eur Heart J,2017,38(4):268

265 Priori SG,Wilde AA,Horie M,et al.HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes:document endorsed by HRS,EHRA,and APHRS in May 2013 and by ACCF,AHA,PACES,and AEPC in June 2013[J].Heart Rhythm,2013,10(12):1 932

266 Gao Y,Liu W,Li C,et al.Common genotypes of long QT syndrome in China and the role of ECG prediction[J].Cardiology,2016,133(2):73

267 Yang Y,Yang Y,Liang B,et al.Identification of a Kir3.4 mutation in congenital long QT syndrome[J].Am J Hum Genet,2010,86(6):872

268 Schwartz PJ,Crotti L.QTc behavior during exercise and genetic testing for the long-QT syndrome[J].Circulation,2011,124(20):2 181

269 Moss AJ,Zareba W,Hall WJ,et al.Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome[J].Circulation,2000,101(6):616

270 Goldenberg I,Bradley J,Moss A,et al.Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2:implications for patient management[J].J Cardiovasc Electrophysiol,2010,21(8):893

271 Moltedo JM,Kim JJ,Friedman RA,et al.Use of a cardioselective beta-blocker for pediatric patients with prolonged QT syndrome[J].Pediatr Cardiol,2011,32(1):63

272 Chockalingam P,Crotti L,Girardengo G,et al.Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2:higher recurrence of events under metoprolol[J].J Am Coll Cardiol,2012,60(20):2 092

273 Villain E,Denjoy I,Lupoglazoff JM,et al.Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome[J].Eur Heart J,2004,25(16):1 405

274 Hobbs JB,Peterson DR,Moss AJ,et al.Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome[J].JAMA,2006,296(10):1 249

275 Rashba EJ,Zareba W,Moss AJ,et al.Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome.LQTS Investigators[J].Circulation,1998,97(5):451

276 Jons C,Moss AJ,Goldenberg I,et al.Risk of fatal arrhythmic events in long QT syndrome patients after syncope[J].J Am Coll Cardiol,2010,55(8):783

277 Dorostkar PC,Eldar M,Belhassen B,et al.Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing[J].Circulation,1999,100(24):2 431

278 Schwartz PJ,Priori SG,Cerrone M,et al.Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome[J].Circulation,2004,109(15):1 826

279 Chorin E,Hu D,Antzelevitch C,et al.Ranolazine for Congenital Long-QT Syndrome Type III:Experimental and Long-Term Clinical Data[J].Circ Arrhythm Electrophysiol,2016,9(10)

280 Mazzanti A,Maragna R,Faragli A,et al.Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3[J].J Am Coll Cardiol,2016,67(9):1 053

281 Bos JM,Bos KM,Johnson JN,et al.Left cardiac sympathetic denervation in long QT syndrome:analysis of therapeutic nonresponders[J].Circ Arrhythm Electrophysiol,2013,6(4):705

282 Bai R,Napolitano C,Bloise R,et al.Yield of genetic screening in inherited cardiac channelopathies:how to prioritize access to genetic testing[J].Circ Arrhythm Electrophysiol,2009,2(1):6

283 Priori SG,Napolitano C,Schwartz PJ,et al.Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers[J].JAMA,2004,292(11):1 341

284 Schwartz PJ,Crotti L,Insolia R.Long-QT syndrome:from genetics to management[J].Circ Arrhythm Electrophysiol,2012,5(4):868

285 Liu W,Yang J,Hu D,et al.KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population[J].Hum Mutat,2002,20(6):475

286 Zhou H,Lai W,Zhu W,et al.Genotype-based clinical manifestation and treatment of Chinese long QT syndrome patients with KCNQ1 mutations-R380S and W305L[J].Cardiol Young,2016,26(4):754

287 戈海延,李小梅,江河,等.儿童先天性长QT综合征58例临床特征及治疗分析[J].中华儿科杂志,2019,57(4):272

288 周慧,Zhang L,Ghani AR,等.高发心脏性猝死的3型长QT综合征一家系报道[J].中华心血管病杂志,2015,43(12):1 046

289 Aziz PF,Wieand TS,Ganley J,et al.Genotype- and mutation site-specific QT adaptation during exercise,recovery,and postural changes in children with long-QT syndrome[J].Circ Arrhythm Electrophysiol,2011,4(6):867

290 Laksman ZW,Hamilton RM,Chockalingam P,et al.Mutation location effect on severity of phenotype during exercise testing in type 1 long-QT syndrome:impact of transmembrane and C-loop location[J].J Cardiovasc Electrophysiol,2013,24(9):1 015

291 Goldenberg I,Horr S,Moss AJ,et al.Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals[J].J Am Coll Cardiol,2011,57(1):51

292 Zhang C,Kutyifa V,Moss AJ,et al.Long-QT syndrome and therapy for attention deficit/hyperactivity disorder[J].J Cardiovasc Electrophysiol,2015,26(10):1 039

293 Roden DM.Drug-induced prolongation of the QT interval[J].N Engl J Med,2004,350(10):1 013

294 杨兵,曹克将,单其俊,等.1 065例健康汉族人Brugada心电图征发生率的初步调查[J].中华心律失常学杂志,2005,9(3):214

295 Gehi AK,Duong TD,Metz LD,et al.Risk stratification of individuals with the Brugada electrocardiogram:a meta-analysis[J].J Cardiovasc Electrophysiol,2006,17(6):577

296 Ackerman MJ,Priori SG,Willems S,et al.HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies:this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)[J].Europace,2011,13(8):1 077

297 Hong K,Hu J,Yu J,et al.Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation[J].Eur J Hum Genet,2012,20(11):1 189

298 Romero J,Li DL,Avendano R,et al.Brugada syndrome:progress in genetics,risk stratification and management[J].Arrhythm Electrophysiol Rev,2019,8(1):19

299 Fauchier L,Isorni MA,Clementy N,et al.Prognostic value of programmed ventricular stimulation in Brugada syndrome according to clinical presentation:an updated meta-analysis of worldwide published data[J].Int J Cardiol,2013,168(3):3 027

300 Probst V,Veltmann C,Eckardt L,et al.Long-term prognosis of patients diagnosed with Brugada syndrome:Results from the FINGER Brugada Syndrome Registry[J].Circulation,2010,121(5):635

301 Nademanee K,Veerakul G,Mower M,et al.Defibrillator Versus beta-Blockers for Unexplained Death in Thailand (DEBUT):a randomized clinical trial[J].Circulation,2003,107(17):2 221

302 Belhassen B,Rahkovich M,Michowitz Y,et al.Management of Brugada syndrome:thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs[J].Circ Arrhythm Electrophysiol,2015,8(6):1 393

303 Brugada R,Brugada J,Antzelevitch C,et al.Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts[J].Circulation,2000,101(5):510

304 Shimeno K,Takagi M,Maeda K,et al.Usefulness of multichannel Holter ECG recording in the third intercostal space for detecting type 1 Brugada ECG:comparison with repeated 12-lead ECGs[J].J Cardiovasc Electrophysiol,2009,20(9):1 026

305 Antzelevitch C,Yan GX,Ackerman MJ,et al.J-Wave syndromes expert consensus conference report:Emerging concepts and gaps in knowledge[J].Europace,2017,19(4):665

306 Kapplinger JD,Tester DJ,Alders M,et al.An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing[J].Heart Rhythm,2010,7(1):33

307 Adler A,Rosso R,Chorin E,et al.Risk stratification in Brugada syndrome:clinical characteristics,electrocardiographic parameters,and auxiliary testing[J].Heart Rhythm,2016,13(1):299

308 Priori SG,Napolitano C,Gasparini M,et al.Natural history of Brugada syndrome:insights for risk stratification and management[J].Circulation,2002,105(11):1 342

309 Chen C,Tan Z,Zhu W,et al.Brugada syndrome with SCN5A mutations exhibits more pronounced electrophysiological defects and more severe prognosis:a meta-analysis[J].Clin Genet,2020,97(1):198

310 Andorin A,Behr ER,Denjoy I,et al.Impact of clinical and genetic findings on the management of young patients with Brugada syndrome[J].Heart Rhythm,2016,13(6):1 274

311 Barajas-Martinez H,Hu D,Ontiveros G,et al.Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry[J].Circ Cardiovasc Genet,2011,4(1):51

312 刘欣,李菊香,胡金柱,等.兰尼碱受体2新生基因突变 R2401 H致反复晕厥相关儿茶酚胺敏感性室性心动过速[J].中华心血管病杂志,2017,45(1):39

313 Priori SG,Napolitano C,Memmi M,et al.Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia[J].Circulation,2002,106(1):69

314 Hayashi M,Denjoy I,Extramiana F,et al.Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia[J].Circulation,2009,119(18):2 426

315 Hwang HS,Hasdemir C,Laver D,et al.Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia[J].Circ Arrhythm Electrophysiol,2011,4(2):128

316 Jabbari J,Jabbari R,Nielsen MW,et al.New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia[J].Circ Cardiovasc Genet,2013,6(5):481

317 Marsman RF,Barc J,Beekman L,et al.A mutation in CALM1 encoding calmodulin in familial idiopathic ventricular fibrillation in childhood and adolescence[J].J Am Coll Cardiol,2014,63(3):259

318 王小嘉,路宏,白玉云,等.早期复极综合征流行病学调查研究[J].心电学杂志,2003,22(3):137

319 Rosso R,Kogan E,Belhassen B,et al.J-point elevation in survivors of primary ventricular fibrillation and matched control subjects:incidence and clinical significance[J].J Am Coll Cardiol,2008,52(15):1 231

320 Liu X,Shen Y,Xie J,et al.A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance:A Chinese family study[J].PLoS One,2017,12(5):e0177532

321 Adhikarla C,Boga M,Wood AD,et al.Natural history of the electrocardiographic pattern of early repolarization in ambulatory patients[J].Am J Cardiol,2011,108(12):1 831

322 Sinner MF,Porthan K,Noseworthy PA,et al.A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern[J].Heart Rhythm,2012,9(10):1 627

323 Nademanee K,Haissaguerre M,Hocini M,et al.Mapping and ablation of ventricular fibrillation associated with early repolarization syndrome[J].Circulation,2019,140(18):1 477

324 Wu ZJ,Huang Y,Fu YC,et al.Characterization of a Chinese KCNQ1 mutation (R259H) that shortens repolarization and causes short QT syndrome 2[J].J Geriatr Cardiol,2015,12(4):394

325 Hu D,Li Y,Zhang J,et al.The phenotypic spectrum of a mutation hotspot responsible for the short QT syndrome[J].JACC Clin Electrophysiol,2017,3(7):727

326 石少波,Barajas-Martinez H,胡丹.遗传性短QT综合征的研究进展[J].中华心血管病杂志,2019,47(5):413

327 Mazzanti A,Kanthan A,Monteforte N,et al.Novel insight into the natural history of short QT syndrome[J].J Am Coll Cardiol,2014,63(13):1 300

328 Dhutia H,Malhotra A,Parpia S,et al.The prevalence and significance of a short QT interval in 18,825 low-risk individuals including athletes[J].Br J Sports Med,2016,50(2):124

329 Giustetto C,Di Monte F,Wolpert C,et al.Short QT syndrome:clinical findings and diagnostic-therapeutic implications[J].Eur Heart J,2006,27(20):2 440

330 Bun SS,Maury P,Giustetto C,et al.Electrical storm in short-QT syndrome successfully treated with Isoproterenol[J].J Cardiovasc Electrophysiol,2012,23(9):1 028

331 Silversides CK,Harris L,Haberer K,et al.Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes[J].Am J Cardiol,2006,97(8):1 206

332 European Society of Gynecology (ESG),Association for European Paediatric Cardiology (AEPC),German Society for Gender Medicine (DGesGM),et al.ESC Guidelines on the management of cardiovascular diseases during pregnancy:the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)[J].Eur Heart J,2011,32(24):3 147

333 庞暘,程宽,徐烨,等.右心室流出道起源的室性心律失常消融靶点电生理特性分析及其判断标准的回顾性研究[J].中华心律失常学杂志,2018,22(6):466

334 Regitz-Zagrosek V,Roos-Hesselink JW,Bauersachs J,et al.2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy[J].Eur Heart J,2018,39(34):3 165

335 Wang YC,Chen CH,Su HY,et al.The impact of maternal cardioversion on fetal haemodynamics[J].Eur J Obstet Gynecol Reprod Biol,2006,126(2):268

336 Moore JS,Teefey P,Rao K,et al.Maternal arrhythmia:a case report and review of the literature[J].Obstet Gynecol Surv,2012,67(5):298

337 Ruys TP,Maggioni A,Johnson MR,et al.Cardiac medication during pregnancy,data from the ROPAC[J].Int J Cardiol,2014,177(1):124

338 Davis RL,Eastman D,McPhillips H,et al.Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy[J].Pharmacoepidemiol Drug Saf,2011,20(2):138

339 Natale A,Davidson T,Geiger MJ,et al.Implantable cardioverter-defibrillators and pregnancy:a safe combination[J]?Circulation,1997,96(9):2 808

340 Hartz J,Clark BC,Ito S,et al.Transvenous nonfluoroscopic pacemaker implantation during pregnancy guided by 3-dimensional electroanatomic mapping[J].HeartRhythm Case Rep,2017,3(10):490

341 Driver K,Chisholm CA,Darby AE,et al.Catheter ablation of arrhythmia during pregnancy[J].J Cardiovasc Electrophysiol,2015,26(6):698

342 Chen G,Sun G,Xu R,et al.Zero-fluoroscopy catheter ablation of severe drug-resistant arrhythmia guided by Ensite NavX system during pregnancy:Two case reports and literature review[J].Medicine (Baltimore),2016,95(32):e4487

343 Szumowski L,Szufladowicz E,Orczykowski M,et al.Ablation of severe drug-resistant tachyarrhythmia during pregnancy[J].J Cardiovasc Electrophysiol,2010,21(8):877

344 褚黎,张军,李燕娜,等.妊娠合并快速心律失常孕妇行心脏射频消融术治疗的临床分析[J].中华妇产科杂志,2016,51(10):759

345 Ishibashi K,Aiba T,Kamiya C,et al.Arrhythmia risk and β-blocker therapy in pregnant women with long QT syndrome[J].Heart,2017,103(17):1 374

346 Friday KP,Moak JP,Fries MH,et al.Catecholaminergic ventricular tachycardia,pregnancy and teenager:are they compatible[J]?Pediatr Cardiol,2015,36(7):1 542

347 Burke MC,Gold MR,Knight BP,et al.Safety and efficacy of the totally subcutaneous implantable defibrillator:2-year results from a pooled analysis of the IDE Study and EFFORTLESS registry[J].J Am Coll Cardiol,2015,65(16):1 605

348 Strewe C,Fichtner S.Completely subcutaneous implantable cardioverter defibrillator:care of S-ICD wearers during childbirth][J].Anaesthesist,2015,64(11):843

349 Saltzberg MT,Szymkiewicz S,Bianco NR.Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator[J].J Card Fail,2012,18(1):21

350 Zhang F,Xu Y,Fang Z,et al.A vector-based algorithm to differentiate septal and free wall sites of origin of ventricular arrhythmias in the right ventricular outflow tract[J].International Journal of Heart Rhythm,2016,1(1) :43

351 李进,郑程,林佳选,等.心室流出道及邻近结构室性心律失常优先与多通道传导再认识[J].中华心律失常学杂志,2019,23(1):43

352 Zhang F,Yang B,Chen H,et al.Noncontact mapping to guide ablation of right ventricular outflow tract arrhythmias[J].Heart Rhythm,2013,10(12):1 895

353 杨延宗,刘少稳,高连君,等.反复单形室性心动过速的导管射频消融治疗[J].中华心律失常学杂志,2001,5(6):336

354 张凤祥,陈明龙,杨兵,等.起源于右心室流出道憩室室性心动过速的导管消融一例[J].中华心律失常学杂志,2011,15(6):458

355 凌天佑,吴立群.磁导航技术结合EnSite Array球囊消融治疗室性早搏二例[J].中华心律失常学杂志,2010,14(6):464

356 Zhang F,Yang B,Chen H,et al.Magnetic versus manual catheter navigation for mapping and ablation of right ventricular outflow tract ventricular arrhythmias:a randomized controlled study[J].Heart Rhythm,2013,10(8):1 178

357 Qiu X,Zhang N,Luo Q,et al.Remote magnetic navigation facilitates the ablations of frequent ventricular premature complexes originating from the outflow tract and the valve annulus as compared to manual control navigation[J].Int J Cardiol,2018,267:94

358 Dong X,Tang M,Sun Q,et al.Usefulness of reversed U-curve technique to enhancemapping and ablation efficiency in the treatment of pulmonary sinus cusp-derived ventricular arrhythmias[J].Am J Cardiol,2018,122(5):814

359 Liao Z,Zhan X,Wu S,et al.Idiopathic ventricular arrhythmias originating from the pulmonary sinus cusp:prevalence,electrocardiographic/electrophysiological characteristics,and catheter ablation[J].J Am Coll Cardiol,2015,66(23):2 633

360 Zhang F,Yang B,Chen H,et al.Non-contact mapping-guided ablation of ventricular arrhythmias originating from the pulmonary artery[J].Europace,2016,18(2):281

361 Heeger CH,Kuck KH,Ouyang F.Catheter ablation of pulmonary sinus cusp-derived ventricular arrhythmias by the reversed U-curve technique[J].J Cardiovasc Electrophysiol,2017,28(7):776

362 Zhang F,Hamon D,Fang Z,et al.Value of a posterior electrocardiographic lead for localization of ventricular outflow tract arrhythmias:The V4/V8 ratio[J].JACC Clin Electrophysiol,2017,3(7):678

363 Ouyang F,Fotuhi P,Ho SY,et al.Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp:electrocardiographic characterization for guiding catheter ablation[J].J Am Coll Cardiol,2002,39(3):500

364 杨平珍,吴书林,陈纯波,等.起源于主动脉窦内反复单形室性心动过速和/或频发室性早搏的心电图特征及射频消融治疗[J].中国心脏起搏与心电生理杂志,2005,19(5):338

365 Li JW,Chen XL,Li YC,et al.Distinct ECG characteristics of idiopathic ventricular arrhythmias originating from four regions of left coronary veins[J].Int J Cardiol,2014,175(1):181

366 Zang M,Zhang T,Mao J,et al.Beneficial effects of catheter ablation of frequent premature ventricular complexes on left ventricular function[J].Heart,2014,100(10):787

367 黄从新.室性早搏诱发的心动过速性心肌病[J].中国心脏起搏与心电生理杂志,2010,24(3):189

368 范鲍函,吴红平,徐艳,等.射频消融术对室性心律失常早期心功能减退患者左心室收缩和舒张功能的影响[J].中华心律失常学杂志,2019,23(4):315

369 Huang CX,Liang JJ,Yang B,et al.Quality of life and cost for patients with premature ventricular contractions by radiofrequency catheter ablation[J].Pacing Clin Electrophysiol,2006,29(4):343

370 Lv W,Zhou X,Yiming G,et al.Idiopathic premature ventricular complexes originating from the distal great cardiac vein:Clinical,cardiac and electrophysiological characteristics and catheter ablation outcome[J].Life Sci,2018,202:61

371 Chen H,Shehata M,Swerdlow C,et al.Intramural outflow tract ventricular tachycardia:anatomy,mapping,and ablation[J].Circ Arrhythm Electrophysiol,2014,7(5):978

372 詹贤章,李腾,杨平珍,等.经冠状静脉系统导管射频消融心外膜室性心律失常[J].中国心脏起搏与心电生理杂志,2013,27(1):17

373 Wang JS,Shen YG,Yin RP,et al.The safety of catheter ablation for premature ventricular contractions in patients without structural heart disease[J].BMC Cardiovasc Disord,2018,18(1):177

374 Ouyang F,Mathew S,Wu S,et al.Ventricular arrhythmias arising from the left ventricular outflow tract below the aortic sinus cusps:mapping and catheter ablation via transseptal approach and electrocardiographic characteristics[J].Circ Arrhythm Electrophysiol,2014,7(3):445

375 Zhang J,Tang C,Zhang Y,et al.Catheter ablation of premature ventricular complexes arising from the left fascicular system[J].Heart Rhythm,2019,16(4):527

376 Liu Y,Fang Z,Yang B,et al.Catheter ablation of fascicular ventricular tachycardia:long-term clinical outcomes and mechanisms of recurrence[J].Circ Arrhythm Electrophysiol,2015,8(6):1 443

377 徐艳,张凤祥,杨兵,等.左后分支阻滞不能预测左后分支室性心动过速的长期消融成功[J].中华心律失常学杂志,2016,20(6):499

378 李绍龙,龙德勇,廖祁伟,等.导管消融治疗右心室乳头肌起源的室性心律失常[J].中华心律失常学杂志,2018,22(4):358

379 李世倍,王祖禄,梁延春,等.起源于乳头肌特发性室性心律失常的电生理特点及射频导管消融[J].中华心律失常学杂志,2011,15(3):169

380 贾玉和,欧阳非凡,吕秀章,等.心腔内超声心动图指导下经导管射频消融治疗左心室后乳头肌室性早搏[J].中华心律失常学杂志,2013,17(6):418

381 Wu XY,Liang ZG,Tan Z,et al.Radiofrequency catheter ablation of idiopathic ventricular tachycardia and symptomatic premature ventricular contraction originating from valve annulus[J].Chin Med J (Engl),2008,121(22):2 241

382 Bian C,Ma J,Yao S,et al.Transjugular approach for radiofrequency ablation of premature ventricular contractions originating from the superior tricuspid annulus[J].Pacing Clin Electrophysiol,2012,35(12):e358

383 王琎,李梦梦,龙德勇,等.心腔内超声心动图指导的三尖瓣隔瓣瓣下起源室性早搏导管消融[J].中华心律失常学杂志,2019,23(6):492

384 张劲林,苏晞,韩宏伟,等.起源于三尖瓣环的特发性室性心律失常体表心电图特点及射频导管消融治疗[J].中华心律失常学杂志,2008,12(1):12

385 陈求实,范鲍函,张凤祥,等.起源于三尖瓣环室性心律失常导管消融远期成功率[J].中华心律失常学杂志,2019,23(2):154

386 Chen Q,Kirsch GE,Zhang D,et al.Genetic basis and molecular mechanism for idiopathic ventricular fibrillation[J].Nature,1998,392(6673):293

387 Tilz RR,Lin T,Makimoto H,et al.Successful epicardial ablation of electrical storms due to recurrent ventricular fibrillation triggered by premature ventricular contractions[J].Heart Rhythm,2014,11(1):146

388 陈新,华伟.消融治疗心室颤动的可喜尝试[J].中华心律失常学杂志,2003,7(2):69

389 杨平珍,吴书林,詹贤章,等.触发心室颤动室性早搏的射频导管消融治疗一例[J].中华心律失常学杂志,2005,9(5):353

390 梁延春,王祖禄,梁明,等.特发性右室流出道室性早搏触发多形性室性心动过速或心室颤动四例的临床特点[J].中国心脏起搏与心电生理杂志,2012,26(2):107

391 Zipes DP,Link MS,Ackerman MJ,et al.Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities:task force 9:arrhythmias and conduction defects:a scientific statement from the American Heart Association and American College of Cardiology[J].Circulation,2015,132(22):e315

392 Verdile L,Maron BJ,Pelliccia A,et al.Clinical significance of exercise-induced ventricular tachyarrhythmias in trained athletes without cardiovascular abnormalities[J].Heart Rhythm,2015,12(1):78

393 Biffi A,Pelliccia A,Verdile L,et al.Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes[J].J Am Coll Cardiol,2002,40(3):446

394 Harmon KG,Asif IM,Maleszewski JJ,et al.Incidence,cause,and comparative frequency of sudden cardiac death in national collegiate athletic association athletes:a decade in review[J].Circulation,2015,132(1):10

395 Harmon KG,Drezner JA,Wilson MG,et al.Incidence of sudden cardiac death in athletes:a state-of-the-art review[J].Br J Sports Med,2014,48(15):1 185

396 Marijon E,Tafflet M,Celermajer DS,et al.Sports-related sudden death in the general population[J].Circulation,2011,124(6):672

397 Meyer L,Stubbs B,Fahrenbruch C,et al.Incidence,causes,and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age:a 30-year review[J].Circulation,2012,126(11):1 363

398 Marijon E,Bougouin W,Périer MC,et al.Incidence of sports-related sudden death in France by specific sports and sex[J].JAMA,2013,310(6):642

399 Anderson JH,Tester DJ,Will ML,et al.Whole-exome molecular autopsy after exertion-related sudden unexplained death in the young[J].Circ Cardiovasc Genet,2016,9(3):259

400 Bagnall RD,Weintraub RG,Ingles J,et al.A prospective study of sudden cardiac death among children and young adults[J].N Engl J Med,2016,374(25):2 441

401 Semsarian C,Ingles J,Wilde AA.Sudden cardiac death in the young:the molecular autopsy and a practical approach to surviving relatives[J].Eur Heart J,2015,36(21):1 290

402 Maron BJ,Haas TS,Ahluwalia A,et al.Demographics and epidemiology of sudden deaths in young competitive athletes:from the united states national registry[J].Am J Med,2016,129(11):1 170

403 Yankelson L,Sadeh B,Gershovitz L,et al.Life-threatening events during endurance sports:is heat stroke more prevalent than arrhythmic death[J]?J Am Coll Cardiol,2014,64(5):463

404 Maron BJ,Haas TS,Murphy CJ,et al.Incidence and causes of sudden death in U.S.college athletes[J].J Am Coll Cardiol,2014,63(16):1 636

405 Link MS,Myerburg RJ,Estes NA 3rd,et al.Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities:task force 12:emergency action plans,resuscitation,cardiopulmonary resuscitation,and automated external defibrillators:a scientific statement from the American Heart Association and American College of Cardiology[J].Circulation,2015,132(22):e334

406 Brothers JA,Frommelt MA,Jaquiss R,et al.Expert consensus guidelines:Anomalous aortic origin of a coronary artery[J].J Thorac Cardiovasc Surg,2017,153(6):1 440

407 Van Hare GF,Ackerman MJ,Evangelista JA,et al.Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities:task force 4:congenital heart disease:a scientific statement from the American Heart Association and American College of Cardiology[J].Circulation,2015,132(22):e281

408 Ackerman MJ,Zipes DP,Kovacs RJ,et al.Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities:task force 10:the cardiac channelopathies:a scientific statement from the American Heart Association and American College of Cardiology[J].Circulation,2015,132(22):e326

409 Maron BJ,Udelson JE,Bonow RO,et al.Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities:task force 3:hypertrophic cardiomyopathy,arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies,and myocarditis:a scientific statement from the American Heart Association and American College of Cardiology[J].Circulation,2015,132(22):e273

410 Corrado D,Basso C,Pavei A,et al.Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program[J].JAMA,2006,296(13):1 593